First FDA-Approved Cannabis Drug Now Available by Prescription
The first FDA-approved drug derived from cannabis is now available for patients in the United States.
Epidiolex was approved by the FDA in June for the treatment of two forms of epilepsy known as Lennox-Gastaut syndrome and Dravet syndrome. It was classified as a Schedule V substance in September and officially hit the U.S. market last week. The drug can be taken by patients as young as two years old.
“We are delighted to announce that EPIDIOLEX is now available by physician prescription as a new treatment option for patients with LGS and Dravet syndrome, two of the most difficult-to-treat forms of childhood-onset epilepsy,” GW Pharmaceuticals CEO Justin Gover said in a press release. “Because these patients have historically not responded well to available seizure medications, there has been a dire need for new therapies that aim to reduce the frequency and impact of seizures. We are committed to ensuring that these patients can access this novel cannabinoid medicine that has been thoroughly studied in clinical trials, manufactured to assure quality and consistency, and is eligible to be covered by insurance for appropriate patients.”
Read more about the new drug here.